Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Pharmaron Beijing A is a leading provider of comprehensive R&D services for the global pharmaceutical and biotechnology industries. The company offers integrated solutions in drug discovery, development, and manufacturing, encompassing preclinical and clinical studies, drug development, and quality control. Pharmaron Beijing A supports its clients in bringing innovative therapies to market faster by delivering high-quality services and expertise.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Pharmaron Beijing A is scheduled to report its next quarterly earnings on 10/22/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Pharmaron Beijing A last reported quarterly earnings on 8/20/2026 (Q2 2026). Earnings per share (EPS) came in at 0.23 CNY.
Across its last 3 earnings reports, Pharmaron Beijing A stock moved by ±2.5% on average the following day. The largest reaction was +5.4% on 04/28/2026; 2 of 3 reactions were positive.
Pharmaron Beijing A has beaten analyst EPS estimates in 1 of its last 3 evaluated quarters (beat rate: 33.3%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.